open access

Vol 90, No 8 (2019)
ORIGINAL PAPERS Gynecology
Published online: 2019-08-30
Get Citation

Analyzing the clinical significance of postoperative methotrexate in the management of early abdominal pregnancy: analysis of 10 cases

Emmanuel Ansong, Gaby Sukma Illahi, Laien Shen, Xueqing Wu
DOI: 10.5603/GP.2019.0078
·
Pubmed: 31482546
·
Ginekol Pol 2019;90(8):438-443.

open access

Vol 90, No 8 (2019)
ORIGINAL PAPERS Gynecology
Published online: 2019-08-30

Abstract

Objectives: To assess the clinical value and treatment outcomes of postoperative methotrexate (MTX) therapy in the management of early abdominal pregnancy. 

Material and methods: We retrospectively analyzed ten (10) cases of early abdominal pregnancy at our hospital between 7th August, 2006 and 20th April, 2017. 

Results: Out of the ten (10) cases identified, six (6) patients and four (4) patients underwent surgery (laparotomy or laparoscopy) only and surgery (laparotomy or laparoscopy) plus IM 50 mg/m2 methotrexate (MTX) within 24 hours of surgery respectively. The gestation age and serum β-HcG levels were significantly lower (p < 0.05, 6.0 ± 1.82 and 8073.2 ± 9561.0) in the surgery plus MTX group in comparison to (7.33 ± 3.61 and 15625 ± 21275.2) for the surgery only group. Ultrasound imaging findings reported extra uterine pregnancy in all cases and diagnostic surgery was necessary to locate precise site of implantation to plan further treatment. Days of hospitalization were shorter in the surgery + MTX group than in the surgery only group (3.00 ± 0.816 versus 5.66 ± 2.80). 

Conclusions: Earliness in diagnosis coupled with the appropriate (methotrexate) MTX regime could help prevent unwanted complications that could arise from delayed or misdiagnosis.

Abstract

Objectives: To assess the clinical value and treatment outcomes of postoperative methotrexate (MTX) therapy in the management of early abdominal pregnancy. 

Material and methods: We retrospectively analyzed ten (10) cases of early abdominal pregnancy at our hospital between 7th August, 2006 and 20th April, 2017. 

Results: Out of the ten (10) cases identified, six (6) patients and four (4) patients underwent surgery (laparotomy or laparoscopy) only and surgery (laparotomy or laparoscopy) plus IM 50 mg/m2 methotrexate (MTX) within 24 hours of surgery respectively. The gestation age and serum β-HcG levels were significantly lower (p < 0.05, 6.0 ± 1.82 and 8073.2 ± 9561.0) in the surgery plus MTX group in comparison to (7.33 ± 3.61 and 15625 ± 21275.2) for the surgery only group. Ultrasound imaging findings reported extra uterine pregnancy in all cases and diagnostic surgery was necessary to locate precise site of implantation to plan further treatment. Days of hospitalization were shorter in the surgery + MTX group than in the surgery only group (3.00 ± 0.816 versus 5.66 ± 2.80). 

Conclusions: Earliness in diagnosis coupled with the appropriate (methotrexate) MTX regime could help prevent unwanted complications that could arise from delayed or misdiagnosis.

Get Citation

Keywords

abdominal ectopic pregnancy; early abdominal pregnancy; serum β-HcG; methotrexate; diagnostic laparoscopy

About this article
Title

Analyzing the clinical significance of postoperative methotrexate in the management of early abdominal pregnancy: analysis of 10 cases

Journal

Ginekologia Polska

Issue

Vol 90, No 8 (2019)

Pages

438-443

Published online

2019-08-30

DOI

10.5603/GP.2019.0078

Pubmed

31482546

Bibliographic record

Ginekol Pol 2019;90(8):438-443.

Keywords

abdominal ectopic pregnancy
early abdominal pregnancy
serum β-HcG
methotrexate
diagnostic laparoscopy

Authors

Emmanuel Ansong
Gaby Sukma Illahi
Laien Shen
Xueqing Wu

References (25)
  1. Atrash HK, Friede A, Hogue CJ. Abdominal pregnancy in the United States: frequency and maternal mortality. Obstet Gynecol. 1987; 69(3 Pt 1): 333–337.
  2. Sunday-Adeoye I, Twomey D, Egwuatu EV, et al. A 30-year review of advanced abdominal pregnancy at the Mater Misericordiae Hospital, Afikpo, southeastern Nigeria (1976-2006). Arch Gynecol Obstet. 2011; 283(1): 19–24.
  3. Martin J, McCaul J. Emergent Management of Abdominal Pregnancy. Clin Obstet Gynecol. 1990; 33(3): 438–447.
  4. Costa SD, Presley J, Bastert G. Advanced abdominal pregnancy. Obstet Gynecol Surv. 1991; 46(8): 515–525.
  5. Jurkovic D, Mavrelos D. Catch me if you scan: ultrasound diagnosis of ectopic pregnancy. Ultrasound Obstet Gynecol. 2007; 30(1): 1–7.
  6. Vignali M, Busacca M, Brigante C, et al. Abdominal pregnancy as a result of gamete intrafallopian transfer (GIFT) and subsequent treatment with methotrexate: case report. Int J Fertil. 1990; 35(5): 280–283.
  7. Raughley MJ, Frishman GN. Local treatment of ectopic pregnancy. Semin Reprod Med. 2007; 25(2): 99–115.
  8. Crespo R, Campillos JM, Villacampa A, et al. Successful methotrexate treatment of an abdominal pregnancy in the pouch of Douglas. Clin Exp Obstet Gynecol. 2008; 35(4): 289–290.
  9. Koo HS, Bae JuY, Kang IS, et al. Laparoscopic management of early primary peritoneal pregnancy: a case report. Clin Exp Reprod Med. 2011; 38(2): 109–114.
  10. Fylstra DL. Ectopic pregnancy not within the (distal) fallopian tube: etiology, diagnosis, and treatment. Am J Obstet Gynecol. 2012; 206(4): 289–299.
  11. Cobellis L, Stradella L, Messalli EM. Contribution to the choice of therapy in abdominal pregnancy. Panminerva Med. 2000; 42(2): 159–161.
  12. Poole A, Haas D, Magann EF. Early abdominal ectopic pregnancies: a systematic review of the literature. Gynecol Obstet Invest. 2012; 74(4): 249–260.
  13. Stucki D, Buss J. The ectopic pregnancy, a diagnostic and therapeutic challenge. J Med Life. 2008; 1(1): 40–48.
  14. Ginath S, Malinger G, Golan A, et al. Successful laparoscopic treatment of a ruptured primary abdominal pregnancy. Fertil Steril. 2000; 74(3): 601–602.
  15. Shaw SW, Hsu JJ, Chueh HY, et al. Management of primary abdominal pregnancy: twelve years of experience in a medical centre. Acta Obstet Gynecol Scand. 2007; 86(9): 1058–1062.
  16. delRosario R, el-Roeiy A. Abdominal pregnancy on the bladder wall following embryo transfer with cryopreserved-thawed embryos: a case report. Fertil Steril. 1996; 66(5): 839–841.
  17. Shafi SM, Malla MA, Salaam PA, et al. Abdominal pregnancy as a cause of hemoperitoneum. J Emerg Trauma Shock. 2009; 2(3): 196–198.
  18. Tanaka T, Hayashi H, Kutsuzawa T, et al. Treatment of interstitial ectopic pregnancy with methotrexate: report of a successful case. Fertil Steril. 1982; 37(6): 851–852.
  19. Hajenius PJ, Engelsbel S, Mol BW, et al. Randomised trial of systemic methotrexate versus laparoscopic salpingostomy in tubal pregnancy. Lancet. 1997; 350(9080): 774–779.
  20. Alleyassin A, Khademi A, Aghahosseini M, et al. Comparison of success rates in the medical management of ectopic pregnancy with single-dose and multiple-dose administration of methotrexate: a prospective, randomized clinical trial. Fertil Steril. 2006; 85(6): 1661–1666.
  21. Giannopoulos T, Katesmark M. Ruptured tubal ectopic pregnancy with secondary implantation in the pouch of Douglas. J Obstet Gynaecol. 2004; 24(2): 199–200.
  22. Vermesh M, Silva PD, Sauer MV, et al. Persistent tubal ectopic gestation: patterns of circulating beta-human chorionic gonadotropin and progesterone, and management options. Fertil Steril. 1988; 50(4): 584–588.
  23. Gracia CR, Brown HA, Barnhart KT. Prophylactic methotrexate after linear salpingostomy: a decision analysis. Fertil Steril. 2001; 76(6): 1191–1195.
  24. Bachman EA, Barnhart K. Medical management of ectopic pregnancy: a comparison of regimens. Clin Obstet Gynecol. 2012; 55(2): 440–447.
  25. Dhar H, Hamdi I, Rathi B. Methotrexate treatment of ectopic pregnancy: experience at nizwa hospital with literature review. Oman Med J. 2011; 26(2): 94–98.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk
tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl